Aeglea BioTherapeutics Inc (AGLE): AGLE a good buy under .11, huge gap tha...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	319
Posts	22300
Boards Moderated	0
Alias Born	10/22/2009

WARHAMMER

Re: None

Thursday, 06/22/2023 11:15:21 AM

Thursday, June 22, 2023 11:15:21 AM

AGLE a good buy under .11, huge gap that will be filled by shorties. shameless pumping here. lmao

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent AGLE News

Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/30/2024 04:15:23 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/25/2024 08:55:38 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 04/25/2024 08:40:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/25/2024 08:21:55 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/01/2024 08:06:29 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/20/2024 11:14:05 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/18/2024 08:06:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2024 12:31:01 PM
Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/14/2024 08:12:02 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 09:05:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 12:33:03 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:36:15 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:33:03 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:32:12 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:27:52 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:25:02 PM
Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics, Appoints CEO and Additional Directors, and Expands Leadership Team to Develop Next-Generation Therapeutic Combinations for the Treatment of IBD • PR Newswire (US) • 11/27/2023 01:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/23/2023 01:45:06 AM
Aeglea BioTherapeutics Announces Grants of Inducement Awards • PR Newswire (US) • 11/22/2023 10:00:00 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/15/2023 10:18:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 10:14:01 PM

More AGLE News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover